Krsnaa Diagnostics Limited

Equities

KRSNAA

INE08LI01020

Healthcare Facilities & Services

Market Closed - NSE India S.E. 07:43:48 2024-04-26 am EDT 5-day change 1st Jan Change
565.5 INR -1.07% Intraday chart for Krsnaa Diagnostics Limited -3.99% -19.90%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Krsnaa Diagnostics Forms New Wholly-Owned Subsidiary MT
Transcript : Krsnaa Diagnostics Limited, Q3 2024 Earnings Call, Feb 13, 2024
Krsnaa Diagnostics Managing Director to Step Down in March MT
Krsnaa Diagnostics to Form Retail Arm MT
Krsnaa Diagnostics Limited Approves Incorporation of a Wholly Owned Subsidiary Company CI
Krsnaa Diagnostics Limited Announces Change of Managing Director CI
Krsnaa Diagnostics Limited Appoints Prashant Pandurangrao Deshmukh as Chief Executive Officer CI
Krsnaa Diagnostics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Krsnaa Diagnostics Limited Approves Formation of A Wholly Owned Subsidiary of the Company CI
Transcript : Krsnaa Diagnostics Limited, Q2 2024 Earnings Call, Nov 06, 2023
Krsnaa Diagnostics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Transcript : Krsnaa Diagnostics Limited, Q1 2024 Earnings Call, Aug 17, 2023
Krsnaa Diagnostics Limited Appoints Sujoy Sudipta Bose as Company Secretary CI
Krsnaa Diagnostics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Krsnaa Diagnostics Limited Provides Update on Assam Tender CI
Krsnaa Diagnostics Limited Announces Appointment of Sujoy Sudipta Bose as Compliance Officer, Effective July 23, 2023 CI
INDIA STOCKS-IT drags Indian shares; Jio Financial's discovered price above estimates RE
Krsnaa Diagnostics Limited Announces Award of Order CI
Krsnaa Diagnostics Limited Provides Revenue Guidance for the Fiscal Year 2024 and 2025 CI
Transcript : Krsnaa Diagnostics Limited, Q4 2023 Earnings Call, May 29, 2023
Krsnaa Diagnostics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023 CI
Krsnaa Diagnostics Limited Recommends Final Dividend for the Financial Year 2022-2023 CI
Krsnaa Diagnostics Opens MRI and CT Scan Facility in Mumbai's Rajawadi Hospital MT
Krsnaa Diagnostics Limited Announces Commencement of CT Scan Services at Municipal General Hospital, Rajawadi, Ghatkoper, Mumbai CI
Krsnaa Diagnostics Emerges Lowest Bidder for Establishing Diagnostic Centers in Assam, India MT
Chart Krsnaa Diagnostics Limited
More charts
Krsnaa Diagnostics Limited is an India-based diagnostic services provider, both in radiology and pathology. The Company is primarily engaged in the business of providing diagnostic services all over India. The Company is providing radiology and pathology services for X-Ray, computed tomography (CT) scan, magnetic resonance imaging (MRI), mammography, tele- reporting services, and all types of blood and urine investigation. Its technology helps health care professionals diagnose and treat medical problems by imaging the interior of the human body. Its lab services offerings encompass a range of investigations from routine tests to specialized ones. Its health packages include Ayaksham-Total, Bone Health-Advance, Fever Profile-Basic, Hypertension Profile, Menopause Profile-Advance, and Polycystic Ovaries Screening (PCOS), among others. The Company offers its services to public and private hospitals, medical colleges, and community health centers.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
565.5 INR
Average target price
952 INR
Spread / Average Target
+68.35%
Consensus
  1. Stock Market
  2. Equities
  3. KRSNAA Stock
  4. News Krsnaa Diagnostics Limited
  5. Krsnaa Diagnostics Managing Director to Step Down in March